These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 9297532

  • 1. Peptide-MHC complexes assembled following multiple pathways: an opportunity for the design of vaccines and therapeutic molecules.
    Corradin G, Demotz S.
    Hum Immunol; 1997 May; 54(2):137-47. PubMed ID: 9297532
    [Abstract] [Full Text] [Related]

  • 2. Interactions between peptides and major histocompatibility complex molecules during antigen processing and presentation.
    Forquet F, Danilczyk U, Lang Y, Delovitch TL.
    Chem Immunol; 1993 May; 57():63-87. PubMed ID: 8260090
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Endosomal compartment: Also a dock for MHC class I peptide loading.
    Ma W, Van den Eynde BJ.
    Eur J Immunol; 2014 Mar; 44(3):650-3. PubMed ID: 24515851
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Antigen processing and intracellular traffic of antigens and MHC molecules.
    Harding CV, Geuze HJ.
    Curr Opin Cell Biol; 1993 Aug; 5(4):596-605. PubMed ID: 8257600
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
    Svensson M, Pfeifer J, Stockinger B, Wick MJ.
    Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
    [Abstract] [Full Text] [Related]

  • 11. Immunogenicity and tolerogenicity of self-major histocompatibility complex peptides.
    Benichou G, Takizawa PA, Ho PT, Killion CC, Olson CA, McMillan M, Sercarz EE.
    J Exp Med; 1990 Nov 01; 172(5):1341-6. PubMed ID: 1700053
    [Abstract] [Full Text] [Related]

  • 12. The biochemistry and cell biology of antigen presentation by MHC class I and class II molecules. Implications for development of combination vaccines.
    Germain RN.
    Ann N Y Acad Sci; 1995 May 31; 754():114-25. PubMed ID: 7625645
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Antigen processing: a critical factor in rational vaccine design.
    Yewdell JW, Bennink JR.
    Semin Hematol; 1993 Oct 31; 30(4 Suppl 4):26-32; discussion 33-4. PubMed ID: 8303307
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Interactions between peptides and major histocompatibility complex molecules].
    Choppin J.
    Pathol Biol (Paris); 1992 Mar 31; 40(3):257-64. PubMed ID: 1376892
    [Abstract] [Full Text] [Related]

  • 17. Systematically benchmarking peptide-MHC binding predictors: From synthetic to naturally processed epitopes.
    Zhao W, Sher X.
    PLoS Comput Biol; 2018 Nov 31; 14(11):e1006457. PubMed ID: 30408041
    [Abstract] [Full Text] [Related]

  • 18. Exploring the MHC-peptide matrix of central tolerance in the human thymus.
    Adamopoulou E, Tenzer S, Hillen N, Klug P, Rota IA, Tietz S, Gebhardt M, Stevanovic S, Schild H, Tolosa E, Melms A, Stoeckle C.
    Nat Commun; 2013 Nov 31; 4():2039. PubMed ID: 23783831
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. MHC class II loading of high or low affinity peptides directed by Ii/peptide fusion constructs: implications for T cell activation.
    Gregers TF, Fleckenstein B, Vartdal F, Roepstorff P, Bakke O, Sandlie I.
    Int Immunol; 2003 Nov 31; 15(11):1291-9. PubMed ID: 14565927
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.